A Study of Ciltacabtagene Autoleucel (Cilta-Cel) in People With Newly Diagnosed Multiple Myeloma

Full Title

A Phase 2 Multicohort Trial to Further Characterize the Efficacy and Safety of Ciltacabtagene Autoleucel - CARTITUDE-10

Purpose

To learn more about the purpose of this study and to find out who can join, please click here to visit ClinicalTrials.gov for a full clinical trial description.

Contact

For more information or to see if you can join this study, please call Dr. Maximilian Merz’s office at 646-608-3713.

Protocol

26-047

Phase

Phase II (phase 2)

Disease Status

Newly Diagnosed

Investigator

Maximilian Merz

Co-Investigators

Saad Z. Usmani

Diseases

Hematology › Multiple Myeloma

Locations

Memorial Sloan Kettering Cancer Center
Memorial Sloan Kettering Commack Nonna’s Garden Foundation Center
Memorial Sloan Kettering Basking Ridge
Memorial Sloan Kettering Westchester
Memorial Sloan Kettering Monmouth
Memorial Sloan Kettering Bergen
Memorial Sloan Kettering Nassau

ClinicalTrials.gov ID

NCT07149857

ClinicalTrials.gov

Visit ClinicalTrials.gov for full clinical trial description